Therapeutic options in Charles Bonnet syndrome

Batra, Anil; Bartels, Matthias; Wormstall, H.

doi:10.1111/j.1600-0447.1997.tb09917.x

Cited by 46 publications

(31 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Comprehensive treatment includes providing adequate information to patients and their families, increasing the patient's quality of life, and treating the cause or anxiety disorder secondary to the symptoms. Several anticonvulsant, antipsychotic, and antidepressant agents have been tried, including carbamazepine, valproate, gabapentin, levetiracetam, haloperidol, olanzapine, risperidone, mirtazapine, venlafaxine, citalopram, donepezil, melperone and ondansetron [24][25][26][27][28][29].…”

Section: Discussionmentioning

confidence: 99%

Visual Hallucinations and Ischemic Stroke: Review of 5 Cases

Şenadım¹,

Balçık²,

Uygun³

et al. 2017

J Neurol Neurophysiol

View full text Add to dashboard Cite

Background: Charles Bonnet syndrome (CBS) presents with complex, vivid, repetitive visual hallucinations that occur in people who have lost some of their vision. The most common cause is senile macular degeneration. CBS can occur, rarely, in patients whose visual pathways are affected. We present five patients with complex visual hallucinations who had occipital lobe lesions after ischemic stroke.

show abstract

Section: Discussionmentioning

confidence: 99%

Visual Hallucinations and Ischemic Stroke: Review of 5 Cases

Şenadım¹,

Balçık²,

Uygun³

et al. 2017

J Neurol Neurophysiol

View full text Add to dashboard Cite

show abstract

“…Recently, Batra et al (1997) reported three cases of CBS which were successfully treated with the atypical neuroleptic melperone, but it is uncertain whether this will be con®rmed by other investigators. Thus, at present, several attempts are required to establish the treatment of CBS.…”

Section: Introductionmentioning

confidence: 90%

Effect of carbamazepine and clonazepam combination on Charles Bonnet Syndrome: a case report

Terao

1998

Hum. Psychopharmacol. Clin. Exp.

View full text Add to dashboard Cite

There is no established treatment for Charles Bonnet Syndrome (CBS). As a naturalistic study, a 68-year-old woman with CBS received carbamazepine alone, carbamazepine plus clonazepam, clonazepam alone, and again, carbamazepine plus clonazepam, consecutively. As a result, the combined use of carbamazepine and clonazepam was most eective. The present results suggest that carbamazepine and clonazepam combination can be useful in the treatment of CBS in some patients. #

show abstract

“…A continuación presentamos una síntesis de las terapias farmacológicas que a nuestro conocimiento se han reportado en la bibliografía médica 12,[35][36][37][38][39][40][41][42][43][44][45][46][47][48][49] (cuadro 1).…”

Section: 35unclassified

Alucinaciones visuales en pacientes con privación sensorial: ¿síndrome de Charles Bonnet?

Yoldi‐Negrete

Ramı́rez-Bermúdez

Ruiz-Chow

et al. 2015

View full text Add to dashboard Cite

IntroductionSome patients, after brain or peripheral injuries, lose a sensory function, such as sight or hearing, but paradoxically experience complex hallucinations related to the function they have lost. It is known that this phenomenon may appear with injuries at any level in the visual pathway, especially in the retina. ObjectiveTo review the existent bibliography on the Charles Bonnet syndrome to establish the state of the art with regards to this phenomenon. MethodThe databases PubMed and PsychInfo were searched for articles containing the following keywords: Charles Bonnet syndrome; visual hallucinations; peduncular hallucinosis; Charles Bonnet; sensory deprivation. We included those related to the subject. We also included the classic texts referring to this phenomenon and the articles mentioned in the literature. ResultsIn the present study, we describe the history of Charles Bonnet syndrome, clinical presentation, risk factors, diagnostic criteria, treatment employed, similar conditions and the theories seeking to explain it. Discussion and conclusionTo date, the diagnostic criteria for Charles Bonnet syndrome remain controversial, especially those concerning the absolute preservation of insight as a sine qua non factor to establish the diagnosis. Conclusion: Described since the 18th century, the Charles Bonnet syndrome corresponds to the prototype of visual hallucinations in patients with visual deprivation, although, according to the present review, its phenomenology is vast, remaining unclear if it corresponds to the prototype of hallucinations with preserved insight.Key words: Charles Bonnet syndrome, visual formed hallucinations, insight, neuropsychiatry. RESUMEN IntroducciónExisten pacientes que, después de lesiones cerebrales o periféricas, pierden alguna función sensorial, como la vista o el oído. Paradóji-camente, después de perder esta función, presentan alucinaciones complejas relacionadas con la función perdida. Se sabe que este fenómeno puede presentarse ante lesiones en cualquier nivel de la vía visual, especialmente en el nivel de la retina. ObjetivoRevisar la bibliografía existente acerca del síndrome de Charles Bonnet para conocer los últimos avances con respecto a este fenómeno. MétodoSe revisaron las bases de datos de PubMed y PsychInfo con las siguientes palabras clave: síndrome de Charles Bonnet; alucinaciones visuales; alucinosis peduncular; Charles Bonnet; privación sensorial. Se incluyeron aquellos artículos que efectivamente trataran del tema. Asimismo, se revisaron los textos clásicos referentes a este síndrome y los artículos mencionados en la bibliografía encontrada. ResultadosEn el presente artículo se describe la historia del síndrome, el fenó-meno clínico, los factores de riesgo, los criterios diagnósticos, los tratamientos empleados, otros fenómenos similares y las teorías propuestas para explicarlo. Discusión y conclusiónA la fecha continúan siendo controvertidos los criterios diagnósticos del síndrome de Charles Bonnet, en especial en lo referente a la preserv...

show abstract

Therapeutic options in Charles Bonnet syndrome

Cited by 46 publications

References 16 publications

Visual Hallucinations and Ischemic Stroke: Review of 5 Cases

Visual Hallucinations and Ischemic Stroke: Review of 5 Cases

Effect of carbamazepine and clonazepam combination on Charles Bonnet Syndrome: a case report

Alucinaciones visuales en pacientes con privación sensorial: ¿síndrome de Charles Bonnet?

Contact Info

Product

Resources

About